- Zimmer Biomet Holdings, Inc. is a global medical technology leader specializing in products that enhance mobility and health, with a strong focus on integrated digital and robotic technologies.
- In 2026, Zimmer Biomet supported the first complete robotic-assisted shoulder replacement in an ambulatory surgery center and appointed Dr. Jonathan M. Vigdorchik as Chief Science, Technology, and Medical Affairs Officer to lead advancements in AI and robotics.
- The company has established partnerships with healthcare providers and institutions, leveraging its innovative technologies to improve surgical outcomes and patient experiences.
- Zimmer Biomet's ideal buyers are healthcare providers and surgical centers looking to enhance operational efficiency and patient care through advanced medical technologies, making it a critical time for sales teams to engage with them as they innovate in robotic-assisted surgery.
Zimmer Biomet Holdings operates with a singular department, Engineering, which comprises the entire workforce of 17,000 employees. This concentration in engineering indicates a strong emphasis on product development and innovation within the medical products and equipment sector. The absence of additional departments suggests a streamlined operational structure focused on engineering excellence.
The company is headquartered in Warsaw, Indiana, with no additional locations reported, indicating a centralized operational model. The workforce is entirely categorized under 'Other,' which may suggest a remote or distributed work pattern. This geographic concentration in a single location may facilitate collaboration and streamline management processes.
